Abstract: The present invention provides a technique enabling modification of an antibody, particularly regioselective modification of an antibody. More specifically, the present invention provides a compound having an affinity substance to an antibody and a bioorthogonal functional group, represented by the following Formula (I): A-L-E-B (I) wherein A is an affinity substance to an antibody, L is a divalent group comprising a leaving group, E is a divalent group comprising an electrophilic group (i) coupled with the leaving group and (ii) having ability to react with a nucleophilic group in the antibody, B is a bioorthogonal functional group, and the leaving group has ability to be cleaved and eliminated from E by a reaction between the nucleophilic group and the electrophilic group, or a salt thereof, and the like.
Description:Attached , Claims:Attached
| # | Name | Date |
|---|---|---|
| 1 | 202418025196-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [28-03-2024(online)].pdf | 2024-03-28 |
| 2 | 202418025196-STATEMENT OF UNDERTAKING (FORM 3) [28-03-2024(online)].pdf | 2024-03-28 |
| 3 | 202418025196-Sequence Listing in txt [28-03-2024(online)].txt | 2024-03-28 |
| 4 | 202418025196-Sequence Listing in PDF [28-03-2024(online)].pdf | 2024-03-28 |
| 5 | 202418025196-REQUEST FOR EXAMINATION (FORM-18) [28-03-2024(online)].pdf | 2024-03-28 |
| 6 | 202418025196-PROOF OF RIGHT [28-03-2024(online)].pdf | 2024-03-28 |
| 7 | 202418025196-PRIORITY DOCUMENTS [28-03-2024(online)].pdf | 2024-03-28 |
| 8 | 202418025196-POWER OF AUTHORITY [28-03-2024(online)].pdf | 2024-03-28 |
| 9 | 202418025196-FORM 18 [28-03-2024(online)].pdf | 2024-03-28 |
| 10 | 202418025196-FORM 1 [28-03-2024(online)].pdf | 2024-03-28 |
| 11 | 202418025196-DRAWINGS [28-03-2024(online)].pdf | 2024-03-28 |
| 12 | 202418025196-DECLARATION OF INVENTORSHIP (FORM 5) [28-03-2024(online)].pdf | 2024-03-28 |
| 13 | 202418025196-COMPLETE SPECIFICATION [28-03-2024(online)].pdf | 2024-03-28 |
| 14 | 202418025196-FORM 3 [17-09-2024(online)].pdf | 2024-09-17 |